Labviva

Labviva

AI-powered procurement platform for life sciences

Overview

Labviva provides an AI-powered procurement platform for the life sciences sector. It runs a digital marketplace that connects researchers and procurement teams with a broad network of suppliers while integrating with enterprise systems like SAP Ariba, Oracle Procurement Cloud, and JAGGAER so organizations can keep existing contracts and pricing. AI powers advanced search and analyzes product attributes from scientific literature to help users compare products and find cost-saving options, and an automated inventory management system offers real-time stock visibility with AI forecasting and QR-based replenishment. The goal is to streamline life sciences purchasing, reduce costs, and improve lab operations by expanding access to suppliers and providing actionable analytics.

About Labviva

Simplify's Rating
Why Labviva is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$55M

Headquarters

Cambridge, Massachusetts

Founded

2017

Get referred to Labviva

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Labviva raised $25 million in January 2025, bringing total funding to $55 million.
  • The company opened London operations in May 2025 and hired Carlo Iannicola.
  • June 2026 product launches signal active expansion into regulated source-to-pay automation.

What critics are saying

  • General-purpose AI platforms from SAP, Oracle, and Ariba threaten Labviva’s category ownership by 2027.
  • The January 2026 commercial gap on Analytics and Inventory agents weakens its automation story.
  • If Europe traction stalls after the London launch, the 2025 expansion thesis collapses.

What makes Labviva unique

  • Labviva’s June 2026 Agentic Crew pairs six specialist SLMs with one orchestrator.
  • It integrates with SAP Ariba, Oro, and ELN or LIMS systems without replacing them.
  • The platform targets regulated life sciences procurement, where audit trails and scientific accuracy matter.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$55M

Meets

Industry Average

Funded Over

4 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
Patreon
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Hybrid Work Options

Paid Vacation

Parental Leave

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-1%

2 year growth

1%
Associated Press
Jun 24th, 2026
Labviva unveils agentic AI architecture to automate procurement in life sciences R&D

Labviva, a procurement platform for life sciences R&D, has launched The Agentic Crew, an AI architecture combining specialised Small Language Models with a large language model orchestrator to automate procurement processes in regulated industries. The system features six specialist agents handling purchasing, sourcing, compliance, domain expertise, analytics and inventory management. The Boston-based company addresses limitations of general-purpose AI models, which co-founder Nicholas Rioux says are costly and prone to hallucinations in specialised contexts. Labviva's approach uses custom-trained SLMs for specific tasks, coordinated by an LLM orchestrator that integrates with existing enterprise systems. The architecture emphasises compliance through logged actions, decision trails and individual agent validation. The platform integrates with major procurement systems including Oro and SAP Ariba.

GlobeNewswire
Jun 24th, 2026
Labviva launches "The Agentic Crew": A purpose-built AI architecture to transform procurement in Regulated Industries.

Labviva launches "The Agentic Crew": A purpose-built AI architecture to transform procurement in Regulated Industries. Specialized Small Language Models + LLM Orchestration deliver compliant, defensible, end-to-end source-to-pay automation for life sciences. June 24, 2026 10:03 ET | Source: Labviva BOSTON, June 24, 2026 (GLOBE NEWSWIRE) - Labviva, the intelligent procurement platform purpose-built for life sciences R&D, today announced the debut of The Agentic Crew, a first-of-its-kind agentic AI architecture that pairs specialized Small Language Models (SLMs) with a large language model (LLM) orchestrator to automate the full source-to-pay lifecycle for research and development organizations. The announcement, first previewed at the R&D Procurement & Sourcing in Pharma Summit 2026 on June 4, marks a decisive shift in how life sciences enterprises can deploy AI in regulated procurement environments, with compliance, auditability, and scientific accuracy built in by design. The Problem with General-Purpose AI in Pharma Procurement For years, the promise of AI in procurement has been undercut by a fundamental mismatch: general-purpose large language models were never built for the precision demands of scientific sourcing. Labviva's CTO and Co-Founder, Nicholas Rioux, has been candid about the limitations. | "When you actually run a question, if you were to distill the economics down to price per question, they're extremely high in their cost, and they have a maximum amount of hallucinations when it gets to specialty information. They're not as good at understanding complex domains that you need to be able to solve." - Nicholas Rioux, CTO & Co-Founder, Labviva | | / | Rioux's answer is not to abandon AI but to rethink its architecture entirely. Rather than relying on foundation models, Labviva builds its own small language models. Beyond the issues of cost and hallucination, Rioux points to a deeper problem: general-purpose models aren't trained on the context that scientific procurement requires. | "Another part of the problem is that the models aren't trained on the right context. Part of what we're doing is training our SLMs on the specific context relevant to our customers, which improves accuracy and lowers the cost of using agents." - Nicholas Rioux | | / | Introducing The Agentic Crew: Specialists + Orchestrator The Labviva Agentic Crew is built on a simple but powerful equation: | Specialists + Orchestrator = Compliant, Defensible Scale | | / | On one side, a suite of six purpose-built SLM specialist agents - each narrow in domain, deep in expertise, and predictable in behavior. On the other, a broad-reasoning LLM orchestrator that runs the room, coordinating across procurement tools (ERP, P2P, Orchestration), scientific tools (ELN, LIMS), and any other application via MCP. Together they form what Labviva calls the Agentic Crew: fast, efficient, on-device specialists doing the work, with an intelligent orchestrator ensuring it all coheres. THE SIX SPECIALIST AGENTS | AGENT | CAPABILITY | | Purchasing Agent | Autonomously search contracted pricing, published papers, and manufacturer specifications to find optimal buying channel based on product fit, pricing, and availability | | Sourcing Agent | Dynamically scans global marketplaces and catalogs to identify the most cost-effective, reliable suppliers across categories | | Compliance Agent | Validates every transaction against applicable Internal, Region, and EH&S Requirements before execution. | | Domain Agents | Specialty agents for chemistry, genomics, and other scientific disciplines, answering domain questions with high certainty. | | Analytics Agent[1] | Watches spend, flags trends and outliers, and answers natural-language questions with precision and provenance. | | Inventory Agent[1] | Monitors real-time stock levels, proactively triggers replenishments, and optimizes asset allocation across decentralized labs. | | / | / | [1] Not available for commercial purchase. Feature in development. "Each agent is individually validated. Together they execute compliant source-to-pay." Why the Crew Model Wins in Regulated Industries For pharmaceutical, biotech, and academic research organizations operating under strict regulations and institutional compliance frameworks, defensibility is not a feature. It is the foundation. The Labviva crew model was built with this reality in mind. Six compliance-by-design principles define the architecture: | Logged & Reviewable Every agent action is logged, traceable, and reviewable by design. | / | Decision Trail The crew model creates a decision trail at every step, not just at final output. | | Validated Specialists Specialist agents can be individually validated to internal, regional, and EHNS requirements. | / | Flagged & Re-run When one agent produces a suspect result, it is flagged and re-run without disrupting the rest of the workflow. | | Maps to Your Controls The modular architecture maps cleanly onto existing access controls, versioning, and compliance frameworks. | / | Defensible at Audit In regulated industries, defensibility is the product, not a downstream worry. | | / | / | / | A New Reality for R&D Procurement Rioux sees the broader implications as fundamental to how life sciences organizations will operate going forward. | "It's a completely new reality for the world, and that's somewhere we're looking to support. When you start to think about what makes things successful from an AI perspective, a lot of it remains the same. It's your data, it's the data quality, it's having the right access to data, it's how you do your data technical integrations." - Nicholas Rioux | | / | Labviva's agentic platform is designed to integrate natively with the orchestration layers already in place at major pharma enterprises - including platforms like Oro, SAP Ariba, and other leading P2P tools - ensuring the Agentic Crew works alongside existing investments rather than replacing them. Availability | Request a demonstration To learn more contact us through the following link labviva.com/request-a-demo | | / | ABOUT LABVIVA Labviva is the intelligent procurement platform built exclusively for life sciences R&D. Trusted by leading pharmaceutical, biotech, and academic research organizations, Labviva connects scientists with the reagents, instruments, and services they need - with the compliance, data quality, and supplier intelligence that regulated environments demand. Founded by scientists and technologists, Labviva is headquartered in Boston, MA. MEDIA CONTACT Gany Rodriguez [email protected] labviva.com

Perspective Publishing Limited
Apr 10th, 2026
TT Electronics announces new permanent CFO.

TT Electronics announces new permanent CFO. By Michael Griffiths 10/04/2026 TT Electronics has announced the appointment of Ian Ashton as the group's new chief financial officer (CFO). Ashton, who will also become an executive director at TT, is currently the CFO of SIG, a role he has had since 2020. Prior to joining SIG, Ashton served as CFO at Low & Bonar until its acquisition by the Freudenberg Group, and before that he was CFO of Labviva, a US-based technology company. He has also served in several senior financial roles at Smith & Nephew. Ashton will join TT following the completion of his current notice period of up to a maximum of six months. He will succeed Richard Webb in the role, who has been TT's interim CFO since May last year. Webb will continue on an interim basis until Ashton joins TT, and will support an orderly handover. "I'm delighted to have been appointed CFO of TT," Ashton said. "The group has a huge amount of potential, with strong market positions and a clear strategy in place, and I am excited at what lies ahead. I greatly look forward to working alongside Eric and the rest of the management team to help deliver further operational and financial progress." TT's CEO, Eric Lakin, added: "Corporate Finance News is delighted to announce Ian's appointment as CFO. He brings a strong combination of financial expertise, operational insight and leadership experience, which will support the group in building on the positive progress achieved over the past 12 months in creating a clearer strategic direction and a stronger platform for growth. "I would like to thank Richard for his support, and I look forward to working with him to ensure a smooth transition. Ian is an excellent fit for TT and I'm excited about working closely with him."

Genetic Engineering & Biotechnology News
Jun 27th, 2025
Labviva Automates Chemical Supply Chain for the Life Sciences Industry

Labviva announced the general availability of Harper Chemical (HarperChem), a new part of its cloud-based inventory management system (IMS).

PharmiWeb
May 15th, 2025
Labviva Announces Global Expansion, Appoints General Manager Of Europe

Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, and fragmented regulatory environments are disrupting the global supply chain and threatening the life sciences industry worldwide. That’s why Labviva, the leading AI procurement platform for life sciences, today announced its entry into Europe, establishing an international headquarters in London, and appointing life sciences veteran Dr. Carlo Iannicola as general manager. As part of the announcement, the company plans to accelerate global adoption of AI-enabled supply chain procurement while delivering a vast pool of diversified suppliers to Europe’s life sciences community.Resolving a Fragmented Global Life Sciences Supply ChainMcKinsey reports that pharmaceutical procurement is inefficient and time-consuming, citing manual entries consume up to 30% of staff time, while life sciences suppliers struggle to digitize and integrate key data sources. It also recently identified augmented sourcing and realtime inventory optimization as powerful use cases capable of driving mass efficiencies in the sector. With the potential to reduce procurement management costs by up to 10% and increase productivity by up to 80%, AI in biopharmaceutical operations is a $7 billion annual business.The “Amazonification” of Supply Chain ProcurementLabviva instantly connects research organizations with 90% of all life sciences manufacturers in the U.S

Recently Posted Jobs

Sign up to get curated job recommendations

Labviva is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →